These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma. Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955 [TBL] [Abstract][Full Text] [Related]
3. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions. Brčić I; Godschachner TM; Bergovec M; Igrec J; Till H; Lackner H; Scheipl S; Kashofer K; Brodowicz T; Leithner A; Szkandera J; Liegl-Atzwanger B Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002 [TBL] [Abstract][Full Text] [Related]
4. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing. Bourhis A; Caumont C; Quintin-Roué I; Magro E; Dissaux G; Remoué A; Le Noac'h P; Douet-Guilbert N; Seizeur R; Tyulyandina A; Schick U; Merlio JP; Marcorelles P; Cappellen D; Uguen A Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039 [TBL] [Abstract][Full Text] [Related]
5. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769 [TBL] [Abstract][Full Text] [Related]
7. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types. Haberecker M; Töpfer A; Melega F; Moch H; Pauli C Histopathology; 2023 Jun; 82(7):1003-1012. PubMed ID: 36759438 [TBL] [Abstract][Full Text] [Related]
8. S100 and Pan-Trk Staining to Report NTRK Fusion-Positive Uterine Sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting. Chiang S Int J Gynecol Pathol; 2021 Jan; 40(1):24-27. PubMed ID: 33290352 [TBL] [Abstract][Full Text] [Related]
9. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors. Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788 [TBL] [Abstract][Full Text] [Related]
10. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. Hechtman JF; Benayed R; Hyman DM; Drilon A; Zehir A; Frosina D; Arcila ME; Dogan S; Klimstra DS; Ladanyi M; Jungbluth AA Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467 [TBL] [Abstract][Full Text] [Related]
11. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma. Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278 [TBL] [Abstract][Full Text] [Related]
12. NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification. Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627 [TBL] [Abstract][Full Text] [Related]
13. NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities. Nozzoli F; Lazar AJ; Castiglione F; Campanacci DA; Beltrami G; De Logu F; Caporalini C; Massi D; Roviello G Pathol Oncol Res; 2022; 28():1610237. PubMed ID: 35295613 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST). Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612 [TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Value of Pan-Trk Expression to Detect Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion in CNS Tumours: A Study Using Next-Generation Sequencing Platform. Mohamed F; Kurdi M; Baeesa S; Sabbagh AJ; Hakamy S; Maghrabi Y; Alshedokhi M; Dallol A; Halawa TF; Najjar AA; Fdl-Elmula I Pathol Oncol Res; 2022; 28():1610233. PubMed ID: 35295612 [No Abstract] [Full Text] [Related]
17. Primary NTRK -rearranged Spindle Cell Neoplasm of the Gastrointestinal Tract: A Clinicopathological and Molecular Analysis of 8 Cases. Gao X; Xu S; Zhu P; Lao IW; Yu L; Wang J Am J Surg Pathol; 2024 May; 48(5):623-631. PubMed ID: 38525823 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma. Hung YP; Jo VY; Hornick JL Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752 [TBL] [Abstract][Full Text] [Related]